USANA Health Sciences, Inc. (USNA) Stock Price & Analysis
USANA Health Sciences, Inc. (USNA) — MoonshotScore 73/100 (Strong band), calculated Nov 18, 2026. Price $12.94 (-1.67%), as of the Nov 20, 2026 trading session; market cap $239M.
Educational signal · not a buy or sell recommendation · How to read this
USANA Health Sciences, Inc. · USNA · NYSE
USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products. The company operates primarily through direct sales in the Asia Pacific, the Americas, and Europe.
Price as of Nov 20, 2026
Key Statistics
MoonshotScore v2 · USANA Health Sciences (USNA)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
A strong balance sheet, at a dirt-cheap price, but stalling growth. Business Quality: Solid; Financial Safety: Sound; Valuation: Cheap; Growth Durability: Fading; Momentum: Slipping.
- EPS beat 0 of the last 4 reports
- Altman Z 3.56 · Piotroski F 4
- ROE -5.1% · ROA 3.4% · current ratio 2.59
Holding back: soft growth
Helping: balance-sheet strength, an attractive price
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 73 | Strong | |
| 74 | Strong | |
| 74 | Strong | |
| 73 | Strong | |
| 73 | Strong | |
| 73 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $12.94 | |
| Change on the day | -1.67% | |
| 52-week range | $12.53 – $23.59 | |
| Market capitalisation | $239M | — |
| Price / earnings (trailing) | 45.04 | |
| Shares traded on the day | 158.8K |
Price & events
Other perspectives
Council score for USANA Health Sciences (USNA): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 17, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is USANA Health Sciences (USNA), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. USANA Health Sciences, Inc. (USNA) is listed on NYSE. It employs 1,570 people and is led by Kevin G. Guest. The market values it at $239M.
What do the latest results show for USANA Health Sciences (USNA)?
Short answer · as of
Against analyst estimates the company has EPS beat 0 of the last 4 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $214M | -$7M | -$0.36 (diluted) |
| Dec 2025 | $226M | -$2M | -$0.10 (diluted) |
| Mar 2026 | $250M | $7M | $0.38 (diluted) |
| Jun 2026 | $223M | -$21M | -$1.16 (diluted) |
What are the financial strengths and risks for USANA Health Sciences (USNA)?
Short answer
The MoonshotScore pillars rate balance-sheet strength, an attractive price as strengths. What is holding it back is soft growth. The distress and quality screens read Altman Z 3.56 · Piotroski F 4. Trailing ratios: ROE -5.1% · ROA 3.4% · current ratio 2.59.
Data-derived red flags
- Negative return on equity (-5.1%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 2 of the last 4 reported quarters.
What should you watch next at USANA Health Sciences (USNA)?
Short answer · as of
Analyst estimates on file carry FY2027 revenue $899.08M · EPS 0.55 · 1 analysts.
What the records here don't tell us
- The next earnings date is not yet scheduled in the calendar we read.
Checked against the records this page reads, on the dates shown above.
How does USANA Health Sciences compare with its peers?
Short answer
USANA Health Sciences's score ranks 2nd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $15.53 Nov 20, 2026 | $1.63B | 92 5-pillar Nov 18, 2026 | |
| USANA Health Sciences (USNA) — this page | $12.94 | $239M | 73 |
| $11.08 Nov 20, 2026 | $522M | 71 5-pillar Nov 18, 2026 | |
| $60.77 Nov 19, 2026 | $711M | 67 5-pillar Nov 18, 2026 | |
| $11.91 Nov 20, 2026 | $1.03B | 65 5-pillar Nov 18, 2026 | |
| $6.20 Nov 20, 2026 | $58.2M | 63 5-pillar Nov 18, 2026 | |
| $3.63 Nov 20, 2026 | $295M | 43 5-pillar Nov 18, 2026 | |
| $10.18 Nov 20, 2026 | $176M | 43 5-pillar Nov 18, 2026 | |
| $19.17 Nov 20, 2026 | $290M | 39 5-pillar Nov 18, 2026 | |
| $3.80 Nov 20, 2026 | $185M | 35 5-pillar Nov 18, 2026 | |
| $7.21 Nov 20, 2026 | $181M | 34 5-pillar Nov 18, 2026 | |
| $12.17 Nov 20, 2026 | $514M | 33 5-pillar Nov 18, 2026 | |
| $7.22 Nov 20, 2026 | $723M | 28 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $899.08M
- EPS estimate
- $0.55
Measured against a quoted price of $12.94 (as of Nov 20, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 22, 2026
- Transactions
- 47
- Identified insiders
- 12
- Purchases
- 0
- Sales
- 7
- Other transactions
- 40
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held USNA in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported USNA in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about USANA Health Sciences (USNA)?
What Investors Ask About USANA Health Sciences (USNA)
These answers are editorial: 1 of these 9 answers is drawn from the USNA research dossier (written May 9, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for USNA?
USNA carries the MoonshotScore stated above — the Strong band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. USANA Health Sciences, Inc. develops, manufactures, and sells nutritional and personal care products.
Is USNA a good stock to buy?
Stock Expert AI does not rate USNA buy, sell or hold. USANA Health Sciences, Inc. carries a MoonshotScore, in the Strong band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the USNA stock price today?
The last price recorded for USANA Health Sciences, Inc. (USNA), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does USANA Health Sciences, Inc. do?
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products through a direct sales model. The company's product portfolio includes vitamin and mineral supplements, targeted supplements for specific health needs, meal replacement shakes, snack bars, and skin care products.
What are the key factors to evaluate for USNA?
USANA Health Sciences, Inc. (USNA) holds a MoonshotScore in the high range. To weigh it, start with the trailing P/E under Price & valuation on this page. These partnerships can be established within the next year and contribute to long-term growth. Not financial advice.
How frequently does USNA data refresh on this page?
USNA's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven USNA's recent stock price performance?
USANA Health Sciences, Inc. (USNA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation for high-quality products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider USNA overvalued or undervalued right now?
The trailing P/E of USANA Health Sciences, Inc. (USNA) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of USNA?
Fractional-share availability for USANA Health Sciences, Inc. (USNA) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 17 figures on this page — 7 from Financial Modeling Prep (FMP), 9 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com